Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Geriatricians call for creative and wide-reaching solutions to end-of-life care for patients with dementia

Three University of Chicago geriatricians are calling for creative and wide-reaching solutions to the problem of sub-optimal end-of-life care for patients with dementia.

14 Oct 2004

Asthma research company Synairgen to float on London's Alternative Investment Market

A spin-out company from the University of Southampton specialising in finding and out-licensing treatments for chronic bronchitis (COPD) and the severest forms of asthma, is about to seek a listing on London's Alternative Investment Market (AIM).

13 Oct 2004

New Jersey to receive additional flu vaccine

The New Jersey Department of Health and Senior Services (DHSS) received information on October 5, 2004 that, due to manufacturing problems in the United Kingdom, the United States will have only one-half of the expected supply of the influence vaccine available for this year’s flu season.

13 Oct 2004

Wisconsin has identified its first laboratory confirmed case of influenza this season

Public health officials in the department said the case, confirmed by the Wisconsin State Laboratory of Hygiene to be influenza type A (H3 subtype), involves an adult female from Waupaca County.

13 Oct 2004

SARS survivor to share his personal and professional experience of SARS

A Hong Kong SARS survivor who helped lead the territory's response to the disease from his hospital bed will be sharing his personal and professional experience of SARS at an international conference in Wellington next month.

13 Oct 2004

California issues alert and warning about flu vaccine price gouging

California State Attorney General Bill Lockyer has urged consumers and pharmacists to provide his office information about price gouging by flu vaccine suppliers and warned he will take enforcement action against those who exploit the supply shortage by charging unconscionable prices.

13 Oct 2004

FDA and MHRA to cooperate efforts to address manufacturing concerns related Chiron's influenza vaccine

The FDA and the U.K's MHRA have announced their intent to continue in a cooperative effort to address the manufacturing quality concerns related to the production of Chiron's influenza vaccine, Fluvirin, at the company's Liverpool facility.

13 Oct 2004

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

An estimated 42 percent of Americans use herbal medicines or nutritional supplements. Many people taking these products and their physicians are unaware of the adverse reactions they can cause.

13 Oct 2004

Influenza expert is beginning a three-year direct comparison of flu shots versus nasal spray flu vaccine

Flu shots have been around since World War II, and the Centers for Disease Control and Prevention has long recommended shots as a way to prevent influenza in the elderly. The approval of a new nasal spray vaccine begs the question whether those looking to stave off the flu should stick with the tried and true injection or switch to the nasal spray.

13 Oct 2004

CDC and Aventis Pasteur plan to allocate influenza vaccine

The Centers for Disease Control and Prevention (CDC) and Aventis Pasteur announced today the first phase of the plan to allocate influenza vaccine in response to the recently announced loss of half of the nation’s expected flu vaccine supply for the 2004-2005 season.

12 Oct 2004

New research points to potential new treatments for sickle cell disease

New research from the University of North Carolina at Chapel Hill reveals why red blood cells from people with sickle cell disease are stickier than healthy red cells, pointing the way to potential new treatments for sickle cell disease.

12 Oct 2004

Study finds new vaccine against pneumococcal has minor adverse effects but continued surveillance is warranted

Examination of reports from the first two years after licensure of a new vaccine against pneumococcal infections indicates that the majority of adverse effects are minor, but that continued surveillance is warranted, according to a study in the October 13 issue of JAMA.

12 Oct 2004

Biomedical engineers receive $11.5 million to study how white blood cells navigate

We all know the power of touch: A whack on the skull – or a hug – can convey more information than other forms of communication ever can. It turns out the same is true inside our bodies

12 Oct 2004

Health care providers need to work together to ensure that high-risk individuals get the flu shot

Dr. Eric E. Whitaker, Illinois state public health director, is encouraging health care providers to work together to ensure that high-risk individuals get the flu shot.

11 Oct 2004

Respiratory therapists are at an increased risk of developing asthma

Respiratory therapists are at an increased risk of developing asthma and asthma-related symptoms due to their involvement in the diagnosis and treatment of patients with respiratory conditions.

11 Oct 2004

Exposure to tobacco smoke and pollutants increases childhood risk of asthma

Children prenatally exposed to pollutants, such as motor vehicle exhaust, and postnatally exposed to environmental tobacco smoke (ETS) may be more likely to suffer from asthma and related symptoms early in life.

11 Oct 2004

Pharmacists respond to unprecedented demand for the flu vaccine in the wake of the current shortage

Pharmacists are responding to unprecedented demand for the flu vaccine in the wake of the current shortage. The pharmacist is on the front line in addressing consumers’ questions and concerns about the availability of the vaccine and in helping Americans understand the CDC’s priorities for administration of the immunization.

10 Oct 2004

Flu vaccine shortage highlights need to accelerate the approval of affordable generic biopharmaceuticals and vaccines

Following the announcement that the nation is facing a flu vaccine shortage this year, the Generic Pharmaceutical Association (GPhA) renewed its call for the Food and Drug Administration (FDA) and Congress to move forward to accelerate the approval of affordable generic biopharmaceuticals and vaccines.

8 Oct 2004

Repeated re-testing of women with a history of chlamydia is a cost-effective strategy for preserving reproductive health

Researchers from the Harvard School of Public Health assessed the cost-effectiveness and clinical benefits of currently existing guidelines and new, proposed guidelines for screening women for chlamydia.

8 Oct 2004

Researchers have found a starting point to establishing the genetic basis for sinus disease

In a three-year analysis of more than 10,500 genes, one-third of the human genome, researchers at Johns Hopkins have found a starting point to establishing the genetic basis for sinus disease and the growth of nasal polyps, illnesses not well understood despite their prevalence.

8 Oct 2004

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Geriatricians call for creative and wide-reaching solutions to end-of-life care for patients with dementia

Asthma research company Synairgen to float on London's Alternative Investment Market

New Jersey to receive additional flu vaccine

Wisconsin has identified its first laboratory confirmed case of influenza this season

SARS survivor to share his personal and professional experience of SARS

California issues alert and warning about flu vaccine price gouging

FDA and MHRA to cooperate efforts to address manufacturing concerns related Chiron's influenza vaccine

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

Influenza expert is beginning a three-year direct comparison of flu shots versus nasal spray flu vaccine

CDC and Aventis Pasteur plan to allocate influenza vaccine

New research points to potential new treatments for sickle cell disease

Study finds new vaccine against pneumococcal has minor adverse effects but continued surveillance is warranted

Biomedical engineers receive $11.5 million to study how white blood cells navigate

Health care providers need to work together to ensure that high-risk individuals get the flu shot

Respiratory therapists are at an increased risk of developing asthma

Exposure to tobacco smoke and pollutants increases childhood risk of asthma

Pharmacists respond to unprecedented demand for the flu vaccine in the wake of the current shortage

Flu vaccine shortage highlights need to accelerate the approval of affordable generic biopharmaceuticals and vaccines

Repeated re-testing of women with a history of chlamydia is a cost-effective strategy for preserving reproductive health

Researchers have found a starting point to establishing the genetic basis for sinus disease

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in